Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SZLS finally jumps to seven with 213k vol on the ATS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(68)
•••
Comment by TrippinAgain01on Jun 01, 2023 10:15pm
112 Views
Post# 35476179

RE:RE:SZLS finally jumps to seven with 213k vol on the ATS

RE:RE:SZLS finally jumps to seven with 213k vol on the ATS I really hate when Tripp/SZ always bring up that they have tested over 100K patients yada yada yada... This was intruguing to me to when I first heard this in 2018 lol, since 2018 they have added like 2K tests lol...

but they bring it up at as early as they can to trick people into thinking it is currently being used on a wide scale. All smoke and mirrors its so disgusting.

How about SZ/Tripp just actually get some work done and report actual good news lol... its sooo hard for them. Are they even trying? 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities